Literature DB >> 28346820

Blastomyces dermatitidis serine protease dipeptidyl peptidase IVA (DppIVA) cleaves ELR+ CXC chemokines altering their effects on neutrophils.

Jenna Lorenzini1, J Scott Fites1, Jeniel Nett2,3, Bruce S Klein1,2,3.   

Abstract

Blastomycosis elicits a pyogranulomatous inflammatory response that involves a prominent recruitment of neutrophils to the site of infection. Although neutrophils are efficiently recruited to the site of infection, this event is paradoxically coupled with the host's inability to control infection by Blastomyces dermatitidis, the causative agent. The mechanisms underlying this characteristic pyogranulomatous response and inability of neutrophils to kill the yeast are poorly understood. We recently reported that the fungal protease dipeptidyl peptidase IVA (DppIVA) promotes B. dermatitidis virulence by cleaving a dipeptide from the N-terminus of C-C chemokines and granulocyte/macrophage-colony stimulating factor, thereby inactivating them. Herein, we present evidence that DppIVA can also truncate the N-terminus of members of the ELR+ CXC chemokine family, which are known to modulate neutrophil function. We show that the DppIVA cleaved form of human (h) CXCL-2, for example, hCXCL-2 (3-73), is a more potent neutrophil chemoattractant than its intact counterpart, but hCXCL-2 (3-73) is conversely impaired in its ability to prime the reactive oxygen species response of neutrophils. Thus, DppIVA action on ELR+ CXC chemokines may promote the pyogranulomatous response that is typical of blastomycosis, while also explaining the inability of neutrophils to control infection.
© 2017 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28346820      PMCID: PMC5544578          DOI: 10.1111/cmi.12741

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  44 in total

1.  Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors.

Authors:  A Yuo; S Kitagawa; T Kasahara; K Matsushima; M Saito; F Takaku
Journal:  Blood       Date:  1991-11-15       Impact factor: 22.113

2.  Ultrastructural localization of cytochrome b in the membranes of resting and phagocytosing human granulocytes.

Authors:  A J Jesaitis; E S Buescher; D Harrison; M T Quinn; C A Parkos; S Livesey; J Linner
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 3.  The evolution of mammalian chemokine genes.

Authors:  Hisayuki Nomiyama; Naoki Osada; Osamu Yoshie
Journal:  Cytokine Growth Factor Rev       Date:  2010-08       Impact factor: 7.638

4.  Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms.

Authors:  A Wuyts; C Govaerts; S Struyf; J P Lenaerts; W Put; R Conings; P Proost; J Van Damme
Journal:  Eur J Biochem       Date:  1999-03

5.  The biological activities of gro beta and IL-8 on human neutrophils are overlapping but not identical.

Authors:  M Magazin; N Vita; E Cavrois; S Lefort; J C Guillemot; P Ferrara
Journal:  Eur Cytokine Netw       Date:  1992 Sep-Oct       Impact factor: 2.737

6.  Interactions between human granulocytes and Blastomyces dermatitidis.

Authors:  J W Sixbey; B T Fields; C N Sun; R A Clark; C M Nolan
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

7.  Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides.

Authors:  N J Laible; G R Germaine
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

8.  Intracellular and extracellular defenses of human phagocytes against Blastomyces dermatitidis conidia and yeasts.

Authors:  D J Drutz; C L Frey
Journal:  J Lab Clin Med       Date:  1985-06

9.  Opposite effects of human monocytes, macrophages, and polymorphonuclear neutrophils on replication of Blastomyces dermatitidis in vitro.

Authors:  E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

10.  A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation.

Authors:  Nathaniel M Weathington; Anneke H van Houwelingen; Brett D Noerager; Patricia L Jackson; Aletta D Kraneveld; F Shawn Galin; Gert Folkerts; Frans P Nijkamp; J Edwin Blalock
Journal:  Nat Med       Date:  2006-02-12       Impact factor: 53.440

View more
  4 in total

Review 1.  The first line of defense: effector pathways of anti-fungal innate immunity.

Authors:  Rebecca A Ward; Jatin M Vyas
Journal:  Curr Opin Microbiol       Date:  2020-11-17       Impact factor: 7.934

2.  An unappreciated role for neutrophil-DC hybrids in immunity to invasive fungal infections.

Authors:  J Scott Fites; Michael Gui; John F Kernien; Paige Negoro; Zeina Dagher; David B Sykes; Jeniel E Nett; Michael K Mansour; Bruce S Klein
Journal:  PLoS Pathog       Date:  2018-05-21       Impact factor: 7.464

Review 3.  The Role of the Interleukin-17 Axis and Neutrophils in the Pathogenesis of Endemic and Systemic Mycoses.

Authors:  Juan David Puerta-Arias; Susana P Mejía; Ángel González
Journal:  Front Cell Infect Microbiol       Date:  2020-12-14       Impact factor: 5.293

Review 4.  Important Mycosis of Wildlife: Emphasis on Etiology, Epidemiology, Diagnosis, and Pathology-A Review: PART 2.

Authors:  Iniobong Chukwuebuka Ikenna Ugochukwu; Iasmina Luca; Nuhu Abdulazeez Sani; Jacinta Ngozi Omeke; Madubuike Umunna Anyanwu; Amienwanlen Eugene Odigie; Remigius Ibe Onoja; Ohiemi Benjamin Ocheja; Miracle Oluchukwu Ugochukwu; Olabisi Aminah Makanju; Chioma Inyang Aneke
Journal:  Animals (Basel)       Date:  2022-07-26       Impact factor: 3.231

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.